Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1

References

• Rorsman F, Husebye ES, Winqvist O, et al. Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen. Proc Natl Acad Sci USA. 1995;92:8626–8629.
   PubMed Web of Science ®Google Scholar
• Ekwall O, Hedstrand H, Grimelius L, et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet. 1998;352:279–283.
   PubMed Web of Science ®Google Scholar
• Alimohammadi M, Björklund P, Hallgren Å, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med. 2008;358:1018–1028.
   PubMed Web of Science ®Google Scholar
• Söderbergh A, Myhre AG, Ekwall O, et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2004;89:557–562.
   PubMed Web of Science ®Google Scholar
• Betterle C, Greggio NA, Volpato M. Clinical review 93: autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998;83:1049–1055.
   PubMed Web of Science ®Google Scholar
• Cocco C, Meloni A, Mariotti S, et al. Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1. Autoimmunity. 2012;45:485–494.
   PubMed Web of Science ®Google Scholar
• Bensing S, Fetissov SO, Mulder J, et al. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. PNAS. 2007;104:949–954.
   PubMed Web of Science ®Google Scholar
• Ward L, Paquette J, Seidman E, et al. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab. 1999;84:844–852.
   PubMed Web of Science ®Google Scholar
• Clifton-Bligh P, Lee C, Smith H, et al. The association of diabetes insipidus with hypoparathyroidism. Addison's disease and mucocutaneous candidiasis. Aust NZ J Med. 1980;10:548–551.
   PubMedGoogle Scholar
• Arvanitakis C, Knouss RF. Selective hypopituitarism. Impaired cell-mediated immunity and chronic mucocutaneous candidiasis. JAMA. 1973;225:1492–1495.
   PubMed Web of Science ®Google Scholar
• Cocco C, Meloni A, Boi F, et al. Median eminence dopaminergic nerve terminals: a novel target in autoimmune polyendocrine syndrome? J Clin Endocrinol Metab. 2005;90:4108–4111.
   PubMed Web of Science ®Google Scholar
• Bottazzo GF, Pouplard A, Florin-Christensen A, et al. Autoantibodies to prolactin-secreting cells of human pituitary. Lancet. 1975;2:97–101.
   PubMed Web of Science ®Google Scholar
• O'Dwyer DT, McElduff P, Peterson P, et al. Pituitary autoantibodies in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Acta Biomed. 2007;78:248–254.
   PubMedGoogle Scholar
• Smith CJ, Oscarson M, Rönnblom L, et al. TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus. Scand J Immunol. 2011;73:147–153.
   PubMed Web of Science ®Google Scholar
• Husebye ES, Gebre-Medhin G, Tuomi T, et al. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 1997;82:147–150.
   PubMed Web of Science ®Google Scholar
• Friberg AS, Lundgren T, Malm H, et al. Transplanted functional islet mass: donor, islet preparation, and recipient factors influence early graft function in islet-after-kidney patients. Transplantation. 2012;93:632–638.
   PubMed Web of Science ®Google Scholar
• Adams JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem. 1992;40:1457–1463.
   PubMed Web of Science ®Google Scholar
• Zhang MD, Tortoriello G, Hsueh B, et al. Neuronal calcium-binding proteins 1/2 localize to dorsal root ganglia and excitatory spinal neurons and are regulated by nerve injury. Proc Natl Acad Sci USA. 2014;111:E1149–E1158.
   PubMed Web of Science ®Google Scholar
• Su J, Sandor K, Skold K, et al. Identification and quantification of neuropeptides in naive mouse spinal cord using mass spectrometry reveals [des-Ser1]-cerebellin as a novel modulator of nociception. J Neurochem. 2014;130:199–214.
   PubMed Web of Science ®Google Scholar
• Meager A, Visvalingam K, Peterson P, et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006;3:e289.
   PubMed Web of Science ®Google Scholar
• Bruserud O, Oftedal BE, Landegren N, et al. A longitudinal follow-up of autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 2016;101:2975–2983.
   PubMed Web of Science ®Google Scholar
• Wolff AS, Erichsen MM, Meager A, et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab. 2007;92:595–603.
   PubMed Web of Science ®Google Scholar
• Pan H, Mzhavia N, Devi LA. Endothelin converting enzyme-2: a processing enzyme involved in the generation of novel neuropeptides. PPL. 2004;11:461–469.
   PubMed Web of Science ®Google Scholar
• Ahn K, Herman SB, Fahnoe DC. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity. Arch Biochem Biophys. 1998;359:258–268.
   PubMed Web of Science ®Google Scholar
• McMahon EG, Palomo MA, Moore WM, et al. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. Proc Natl Acad Sci USA. 1991;88:703–707.
   PubMed Web of Science ®Google Scholar
• Kashiwabara T, Inagaki Y, Ohta H, et al. Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo. FEBS Lett. 1989;247:73–76.
   PubMed Web of Science ®Google Scholar
• Yanagisawa H, Hammer RE, Richardson JA, et al. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest. 2000;105:1373–1382.
   PubMed Web of Science ®Google Scholar
• Emoto N, Yanagisawa M. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem. 1995;270:15262–15268.
   PubMed Web of Science ®Google Scholar
• Mzhavia N, Pan H, Che FY, et al. Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides. J Biol Chem. 2003;278:14704–14711.
   PubMed Web of Science ®Google Scholar
• Molineaux C, Wilk S. In Fricker LD, editor. Peptide biosynthesis and processing. Boca Raton (FL): CRC Press; 1991. p. 251–282.
   Google Scholar
• Nakagomi S, Kiryu-Seo S, Kiyama H. Endothelin-converting enzymes and endothelin receptor B messenger RNAs are expressed in different neural cell species and these messenger RNAs are coordinately induced in neurons and astrocytes respectively following nerve injury. Neuroscience. 2000;101:441–449.
   PubMed Web of Science ®Google Scholar
• Fetissov SO, Bensing S, Mulder J, et al. Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems. J Comp Neurol. 2009;513:1–20.
   PubMed Web of Science ®Google Scholar
• Rodriguiz RM, Gadnidze K, Ragnauth A, et al. Animals lacking endothelin-converting enzyme-2 are deficient in learning and memory. Genes Brain Behav. 2007;7:418–427.
   Web of Science ®Google Scholar
• Weeraratna AT, Kalehua A, Deleon I, et al. Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues. Exp Cell Res. 2007;313:450–461.
   PubMed Web of Science ®Google Scholar
• Eckman EA, Eckman CB. Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. Biochm Soc Trans. 2005;33:1101–1105.
   PubMed Web of Science ®Google Scholar
• Eckman EA, Watson M, Marlow L, et al. Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem. 2003;278:2081–2084.
   PubMed Web of Science ®Google Scholar
• Eckman EA, Reed DK, Eckman CB. Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme. J Biol Chem. 2001;276:24540–24548.
   PubMed Web of Science ®Google Scholar
• Meloni A, Willcox N, Meager A, et al. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab. 2012;97:1114–1124.
   PubMed Web of Science ®Google Scholar
• Meyer S, Woodward M, Hertel C, et al. AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies. Cell. 2016;166:582–595.
   PubMed Web of Science ®Google Scholar
• Ortmann J, Nett PC, Celeiro J, et al. Downregulation of renal endothelin-converting enzyme 2 expression in early autoimmune diabetes. Exp Biol Med (Maywood). 2006;231:1030–1033.
   PubMed Web of Science ®Google Scholar